References
- Web Collection Ten years in drug discovery. www.nature.com/nrd/collections/10/index.html.
- Petros RA DeSimone JM . Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug Discov.9, 615–627 (2010).
- Delehanty JB Boeneman K Bradburne CE et al. Quantum dots: a powerful tool for understanding the intricacies of nanoparticle-mediated drug delivery. Expert Opin. Drug Deliv.6, 1091–1112 (2009).
- Field LD Delehanty JB Chen YC et al. Peptides for specifically targeting nanoparticles to cellular organelles: Quo vadis? Acc. Chem. Res. 48, 1380–1390 (2015).
- Sapsford KE Algar WR Berti L et al. Functionalizing nanoparticles with biological molecules: developing chemistries that facilitate nanotechnology. Chem. Rev.113, 1904–2074 (2013).
- Min YZ Caster JM Eblan MJ et al. Clinical translation of nanomedicine. Chem. Rev.115, 11147–11190 (2015).
- Law V Knox C Djoumbou Y et al. DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res.42, D1091–1097 (2014).
- Johnson BJ Algar WR Malanoski AP et al. Understanding enzymatic acceleration at nanoparticle interfaces: approaches and challenges. Nano Today9, 102–131 (2014).
- Ansari SA Usain Q . Potential applications of enzymes immobilized on/in nano materials: a review. Biotechnol. Adv.30, 512–523 (2012).
- Ding S Cargill AA Medintz IL et al. Increasing the activity of immobilized enzymes with nanoparticle conjugation. Curr. Opin. Biotechnol.34, 242–250 (2015).
- Algar WR Malonski AP Deschamps JR et al. Proteolytic activity at quantum dot-conjugates: kinetic analysis reveals enhanced enzyme activity and localized interfacial ‘hopping’. Nano Lett.12, 3793–3802 (2012).
- Diaz SA Malanoski A Susumu K et al. Probing the kinetics of quantum dot-based proteolytic sensors. Anal. Bioanal. Chem.407, 7307–7318 (2015).
- Claussen JC Malanoski A Breger JC et al. Probing the enzymatic activity of alkaline phosphatase within quantum dot bioconjugates. J. Phys. Chem C119, 2208–2221 (2015).
- Breger JC Walper SA Oh E et al. Quantum dot display enhances activity of a phosphotriesterase trimer. Chem. Commun.51, 6403–6406 (2015).
- Breger JC Ancona MG Walper S et al. Understanding how nanoparticle attachment enhances phosphotriesterase kinetic efficiency. ACS Nano8, 8491–8503 (2015).
- Zobel M Neder RB Kimber SAJ . Universal solvent restructuring induced by colloidal nanoparticles. Science347, 292–294 (2015).
- Brown CW Oh E Hastman DA et al. Kinetic enhancement of the diffusion-limited enzyme beta-galactosidase when displayed with quantum dots. RSC Adv.5, 93089–93094 (2015).
- Sapsford KE Tyner K Dair B et al. Analyzing nanomaterial bioconjugates: a review of current and emerging techniques for purification and characterization. Anal. Chem.83, 4453–4488 (2011).
- Pfeiffer C Rehbock C Huhn D et al. Interaction of colloidal nanoparticles with their local environment: the (ionic) nanoenvironment around nanoparticles is different from bulk and determines the physico-chemical properties of the nanoparticles. J. R. Soc. Interface11, 20130931 (2014).
- Medintz IL . Universal tools for biomolecular attachment to surfaces. Nat. Mater.5, 842 (2006).
- Walper SA Turner KB Medintz IL . Enzymatic bioconjugation of nanoparticles: developing specificity and control. Curr. Opin. Biotechnol.34, 232–241 (2015).
- Corbo C Molinaro R Parodi A et al. The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery. Nanomedicine11, 81–100 (2016).
- Delehanty JB Breger JC Boeneman Gemmill K et al. Controlling the actuation of therapeutic nanomaterials: enabling nanoparticle-mediated drug delivery. Ther. Deliv.4, 1411–1429 (2013).
- Eifler AC Thaxton CS . Nanoparticle therapeutics: FDA approval, clinical trials, regulatory pathways, and case study. Methods Mol. Biol.726, 325–338 (2011).
- Dennis AM Delehanty JB Medintz IL . Emerging physicochemical phenomena along with new opportunities at the biomolecular nanoparticle interface. J. Phys. Chem. Lett.7, 2139–2150 (2016).